Merios
Lipids

Total Cholesterol 220: Is This Too High?

Total cholesterol 220 is borderline high, but the number alone is misleading. Your LDL, HDL, and triglycerides matter far more.

APR 24, 20266 MIN READLIPIDSMERIOS EDITORIAL
Total Cholesterol 220: Is This Too High?
Contents
  1. Is Total Cholesterol 220 Too High?
  2. Where Does 220 mg/dL Fall?
  3. Why Total Cholesterol Is Misleading
  4. What You Actually Need to Know
  5. Critical Numbers Beyond Total Cholesterol
  6. Why Your TC Is 220
  7. What to Do Next
  8. How Merios Helps
  9. Medical Disclaimer

Is Total Cholesterol 220 Too High?

Not necessarily. Total cholesterol 220 mg/dL is borderline high (200 is the cutoff), but it's incomplete information. Total cholesterol lumps together LDL (bad), HDL (good), and triglycerides, making it a poor standalone predictor of heart disease risk. Two people with TC 220 might have vastly different risk profiles. You need the full lipid panel to know your true cardiovascular risk.

Where Does 220 mg/dL Fall?

CategoryTotal Cholesterol (mg/dL)
Desirable<200
Borderline high200–239
Your value (220)Borderline high
High>240

Why Total Cholesterol Is Misleading

Total cholesterol = LDL + HDL + (Triglycerides ÷ 5)

Example: Two people with TC 220:

  • Person A: LDL 120, HDL 80, TG 100 (low risk; high HDL offsets modest LDL)
  • Person B: LDL 160, HDL 35, TG 200 (high risk; high TG, low HDL, elevated LDL)

Same total cholesterol, completely different risk levels. This is why total cholesterol alone is outdated and misleading.

What You Actually Need to Know

Your full lipid breakdown:

MarkerOptimalYour Action at TC 220
LDL<100Check it. High LDL drives risk.
HDL>50 (women), >40 (men)High HDL protects even with higher TC.
Triglycerides<150Elevated TG + high TC suggests metabolic dysfunction.
LDL particle number (ApoB)<70More predictive of risk than LDL cholesterol.
LDL particle sizeLarge (pattern A)Small particles are more dangerous.

Critical Numbers Beyond Total Cholesterol

LDL cholesterol: The "bad" cholesterol that deposits in artery walls.

  • If LDL is <100, your cholesterol risk is low even if TC is 220.
  • If LDL is >130, you need action regardless of TC.

HDL cholesterol: The "good" cholesterol that removes LDL from arteries.

  • HDL >60 is protective and lowers overall risk.
  • Low HDL (<40 men, <50 women) increases risk.

Triglyceride-to-HDL ratio: Divide triglycerides by HDL. Ratio <2 is healthy; >4 suggests high metabolic and cardiovascular risk.

ApoB: Counts the number of atherogenic particles. Often correlates better with heart disease than LDL cholesterol.

Why Your TC Is 220

Genetics: 50–60% of cholesterol is determined by genes. Some people naturally have higher cholesterol.

Diet high in saturated fat and refined carbs: These raise both LDL and triglycerides.

Excess refined carbs: Refined grains, sugars, and processed foods raise triglycerides more than fat does.

Overweight or sedentary: Extra weight and inactivity raise cholesterol and triglycerides, lower HDL.

Aging: Cholesterol naturally rises with age.

Hypothyroidism: Low thyroid function raises cholesterol.

Metabolic syndrome: Insulin resistance drives high cholesterol, high triglycerides, and low HDL.

What to Do Next

1. Get a complete lipid panel:

  • Total cholesterol (you have this: 220)
  • LDL cholesterol
  • HDL cholesterol
  • Triglycerides
  • Ideally, also ask for:
    • ApoB (particle number)
    • Lp(a) (lipoprotein a — genetic risk factor)
    • hsCRP (inflammation marker)

2. Calculate your 10-year heart disease risk: Your doctor can use:

  • Framingham Risk Score
  • ASCVD Risk Calculator
  • These account for age, sex, blood pressure, smoking, diabetes — not just cholesterol

3. Assess your current state:

  • If LDL is <100 AND HDL is >50 (women) or >40 (men), your TC 220 may not be a major concern.
  • If LDL is >130 OR HDL is <40 (men) or <50 (women), you need action.
  • If triglycerides are >200, you have metabolic dysfunction requiring intervention.

4. Lifestyle changes (first-line treatment):

  • Reduce refined carbs: White bread, pasta, sugar, processed snacks raise both LDL and triglycerides. Replace with whole grains, vegetables, and proteins.
  • Increase soluble fiber: Oats, beans, apples, citrus, barley lower LDL by 3–5%.
  • Add plant sterols: Found in fortified foods, nuts, seeds — lower LDL by 6–10%.
  • Choose lean proteins: Fish (especially fatty fish with omega-3s) > poultry > beef. Limit processed meats.
  • Reduce saturated fat: Limit butter, fatty meats, full-fat dairy. Use olive oil and nuts instead.
  • Exercise 150 minutes weekly: Moderate cardio lowers triglycerides and LDL, raises HDL.
  • Lose 5–10% body weight if overweight: Weight loss directly lowers cholesterol and triglycerides.
  • Sleep 7–9 hours: Poor sleep raises cholesterol.

5. Consider medication if:

  • LDL remains >130 after 3 months of lifestyle changes.
  • You have diabetes, prior heart disease, or strong family history (medication recommended regardless of cholesterol level).
  • Your 10-year risk score is >7.5% (indicates statin therapy).

Most statins safely lower LDL by 30–50%. Discuss options with your doctor.

6. Retest in 3 months: After lifestyle changes, recheck your full lipid panel to assess progress.

How Merios Helps

Merios pulls together your complete lipid profile and tells you at a glance whether TC 220 is a concern or not, based on your LDL, HDL, triglycerides, and ApoB. We flag your actual risk drivers (high triglycerides, low HDL, high ApoB) and track trends over time so you see whether lifestyle changes or medication is working.

Upload your blood test to Merios →


Medical Disclaimer

This article is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor about cholesterol management and medication. Do not start or stop statin therapy without medical guidance. Heart disease risk is complex and personalized; your doctor should guide treatment.

Merios EditorialResearch-backed health insights from the Merios team
Share

Frequently asked questions

Newsletter

Like this? Get the next one in your inbox.

Early access includes our weekly briefing — new biomarker deep-dives, plain-English study breakdowns, nothing else.